Stay updated on AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Sign up to get notified when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.

Latest updates to the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the date from '2023-09-21' to '2025-03-06'.SummaryDifference2%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check34 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check49 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check71 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference1.0%
Stay in the know with updates to AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.